Systemic sclerosis - Globe Thesis

Keyword [Systemic sclerosis] Result: 121 - 140 \| Page: 7 of 9
121.	The Clinical Characteristics Of Patients With Relapsing Polychondritis And Application Of New Inflammatory Markers
122.	Preliminary Exploration Of The Role Of Susceptibility Genes In The Pathogenesis Of Systemic Sclerosis Associated Interstitial Lung Disease
123.	Efficacy Of JAKi In A Mouse Model Of Systemic Sclerosis-Related Interstitial Lung
124.	Clinical Characteristics And Risk Factors Of 170 Cases Of Systemic Sclerosis
125.	Protective Effect And Mechanisms Of Linagliptin On Pulmonary Fibrosis Associated With Systemic Sclerosis
126.	Genomics Of Systemic Sclerosis And Related Autoantibodies In Chinese Han Population
127.	Expression And Clinical Significance Of Autophagy-related Genes In Peripheral Blood Mononuclear Cells Of Systemic Sclerosis
128.	Establishment And Characterization Of A Novel Mouse Model Of Systemic Sclerosis Induced By Immunization With AT1R Peptide
129.	The Effects Of IL-35 On Inflammation And Pathological Changes In Fibrosis Of Systemic Sclerosis
130.	Effect Of Thalidomide On NF-κB Signaling Pathway In Mice With Systemic Sclerosis Induced By Bleomycin
131.	Clinical Characteristics And Prognostic Risk Factors Of Patients With Systemic Sclerosis
132.	The Basic And Clinical Exploration Of The Therapeutic Strategies To Connective Tissue Disease Associated Fibrotic Disease
133.	Retrospective Analysis Of Clinical And Laboratory Features Of 163 Patients With Systemic Sclerosis
134.	The Effects Of Prion Protein On Systemic Sclerosclerosis And Its Mechanism
135.	The Relationship Between Small Intestinal Bacterial Overgrowth And Systemic Sclerosis:A Systematic Review And Meta-analysis
136.	The Mechanism Of Extracellular Matrix Decorin In The Pathogenesis Of Primary Sjogren’s Syndrome And Gut Microbiota Aberration In Patients Of Systemic Sclerosis And Bleomycin-induced Mice Model
137.	Association Study Of TGF-β1 Gene Polymorphisms And Its MRNA Level With LncRNA In Patients With Systemic Sclerosis
138.	Efficacy And Safety Of Mesenchymal Stem Cells In The Treatment Of Systemic Sclerosis:A Meta-analysis
139.	Identification Of Potential Serum Metabolic Biomarkers Of Systemic Sclerosis
140.	Correlation Between The Expression Levels Of Four LncRNAs And The Prevalence And Quality Of Life Of Systemic Sclerosis
<<First <Prev Next> Last>> Jump to